Navigation Links
Somanetics Corporation To Release First Quarter 2010 Financial Results and Host Conference Call March 17, 2010
Date:2/25/2010

TROY, Mich., Feb. 25 /PRNewswire-FirstCall/ -- Somanetics Corporation (Nasdaq: SMTS) will release its financial results for the first quarter ending February 28, 2010 before the opening of the market on Wednesday, March 17, 2010.  In conjunction with releasing its financial results, the Company will host a conference call that morning that will be webcast live at 10:00 a.m. (ET).  

On the conference call, Bruce Barrett, Somanetics' president and chief executive officer, and Bill Iacona, chief financial officer, will review Somanetics' financial results.

To listen to the webcast, visit the Presentations & Webcasts page in the Investor Relations section of Somanetics' website at www.somanetics.com prior to the event's broadcast and click on the "Q1 2010 Somanetics Corporation Conference Call" link.  Interested parties unable to listen to the live call may access the archived version of the call on the Presentations & Webcasts page in the Investor Relations section of Somanetics' website for one year after the call.  

About Somanetics

Somanetics Corporation (Nasdaq: SMTS) develops, manufactures and markets the INVOS® Cerebral/Somatic Oximeter which noninvasively provides accurate, real-time blood oxygen measurements in patients greater than 2.5 kilograms, and trend monitoring of this parameter for individuals of any weight.  The INVOS System is the only commercially-available cerebral/somatic oximeter proven to improve outcomes.  Surgeons, anesthesiologists and other medical professionals can use data provided by the INVOS System, in conjunction with other available data, to identify oxygen imbalances in brain or other body tissue beneath the sensor and take necessary corrective action, potentially improving patient outcomes and reducing the costs of care.  The INVOS System is the clinical reference standard in cerebral/somatic oximetry, with a 12-year market track record, more than 750 clinical references and implementation at more than 780 U.S. hospitals.  Somanetics also develops, manufactures and markets the Vital Sync™ System, a device that integrates data from bedside devices into a single system for enhanced patient assessment and decision making, data management and data storage.  Somanetics supports its customers through a direct U.S. sales force and clinical education team.  Covidien markets INVOS System products in Europe, Canada, the Middle East and South Africa and Edwards Lifesciences represents INVOS System products in Japan.  For more information visit www.somanetics.com.

SOURCE Somanetics Corporation

Back to top

RELATED LINKS
http://www.somanetics.com

'/>"/>

SOURCE Somanetics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Somanetics Corporation to Release Fourth Quarter and Fiscal 2009 Financial Results and Host Conference Call January 21, 2010
2. Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University
3. DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results
4. Microfluidics International Corporation Announces Fourth Quarter and Year-End 2009 Financial Results
5. Pharmos Corporation Reports Fourth Quarter and Full Year 2009 Results
6. DURECT Corporation Invites You to Join Its Fourth Quarter 2009 Earnings Conference Call
7. CEL-SCI Corporation Releases Letter to Shareholders
8. Microfluidics International Corporation to Report Fourth Quarter and Year-end 2009 Financial Results on February 23, 2010
9. Unilife Corporation Commences Trading on the NASDAQ Global Market Under the Ticker Symbol UNIS
10. CEL-SCI Corporation Reports First Quarter 2010 Financial Results
11. Volcano Corporation Completes Acquisition of Lumen Biomedicals Xtract(TM) Thrombus Aspiration Catheter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... , Dec. 5, 2016   Mallinckrodt Pharmaceuticals ... pharmaceutical company, today announced that it received a perfect ... Index (CEI), a national benchmarking survey and report on ... and transgender (LGBT) workplace equality, administered by the Human ... 517 major U.S. businesses which also earned top marks ...
(Date:12/5/2016)... 5, 2016  Cornerstone Pharmaceuticals, Inc., a privately ... from two Phase I trials evaluating its lead ... annual meeting of the American Society of Hematology ... . The two datasets show encouraging efficacy and ... (AML) and T-cell non-Hodgkin,s lymphoma (T-cell NHL), respectively, ...
(Date:12/5/2016)... BOULDER, Colo. , Nov. 29, 2016 ... webinar hosted by Accera, Inc. at 11 ... 9th Annual International Conference on Clinical Trials for Alzheimer,s ... role of metabolism in Alzheimer,s disease and therapeutic targets ... patients. "Following the recent failure of another ...
Breaking Medicine Technology:
(Date:12/6/2016)... ... 2016 , ... CarriersEdge, providers of online safety and compliance training tools for ... Offered in three modules, the courses can be used as an extension to an ... how to stay healthy on the road. , “CarriersEdge is now offering a way ...
(Date:12/6/2016)... ... 06, 2016 , ... Of the variety of ingredients in the food supply, ... contrary to common beliefs that hot dogs include “everything but the oink,” today’s wieners ... Ingredients combined with meat and poultry in a hot dog recipe can add flavor, ...
(Date:12/6/2016)... ... December 06, 2016 , ... The NALA, a boutique marketing agency, is ... Foundation (TBCF), a nonprofit 501(C)(3) organization providing financial and emotional support to families ... To assist TBCF, the NALA recently hosted a Thanksgiving food drive that resulted in ...
(Date:12/6/2016)... (PRWEB) , ... December 06, 2016 , ... ... Autism Center with an Award of Distinction, recognizing the organization as a top ... that excel in the areas of clinical quality, staff satisfaction and qualifications, and ...
(Date:12/6/2016)... Yorba Linda, Ca (PRWEB) , ... December 06, ... ... one of the fastest growing fields in research and development, largely due to ... investigated, including human mesenchymal stem cells (hMSCs) and human induced pluripotent stem cells ...
Breaking Medicine News(10 mins):